{
    "2021-01-11": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：从历史复盘看“高景气度龙头”抱团趋势",
                "features": {
                    "keywords": [
                        "医药",
                        "高景气度",
                        "龙头",
                        "抱团趋势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：维持行业长期看好观点 持续关注创新与高景气细分领域",
                "features": {
                    "keywords": [
                        "医药",
                        "长期看好",
                        "创新",
                        "高景气",
                        "细分领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股异动 | 药明康德(02359)涨超5%创历史新高 获美银证券首次覆盖予“买入”评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "港股",
                        "异动",
                        "历史新高",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "特稿|港股生物科技：2020年“药明双雄”挑大梁，2021年生物科技方兴未艾",
                "features": {
                    "keywords": [
                        "港股",
                        "生物科技",
                        "药明双雄",
                        "2020",
                        "2021"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "比亚迪、海康、三一、长城、药明康德、万华化学等明星股市值均刷新历史新高",
                "features": {
                    "keywords": [
                        "药明康德",
                        "市值",
                        "历史新高",
                        "明星股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "化工",
                        "汽车",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】药明康德(02359-HK)涨3.35%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "涨3.35%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业：期待国产龙头打开内需和国际的双循环",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "国产龙头",
                        "双循环"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物/行业周报：关注业绩超预期的机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩超预期",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "核心资产还能不能追？北上资金给出答案！",
                "features": {
                    "keywords": [
                        "核心资产",
                        "北上资金",
                        "答案"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}